mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.4 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.035 |
0.4 |